US Stock MarketDetailed Quotes

Sana Biotechnology (SANA)

Watchlist
  • 4.670
  • -0.070-1.48%
Close Jan 15 16:00 ET
  • 4.700
  • +0.030+0.64%
Post 19:35 ET
1.24BMarket Cap-4.86P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sana Biotechnology (SANA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-29.54%43.52M
2.01%50.36M
-54.27%50.63M
-6.97%272.72M
-43.87%50.87M
2,731.77%61.76M
-57.54%49.37M
31.73%110.72M
7.55%293.14M
10.80%90.62M
Selling and administrative expenses
-26.81%10.29M
-37.11%10.34M
-29.41%11.48M
-12.63%64.04M
-16.87%17.28M
-26.75%14.05M
-0.75%16.44M
-2.96%16.27M
2.43%73.3M
-10.88%20.78M
-General and administrative expense
-26.81%10.29M
-37.11%10.34M
-29.41%11.48M
-12.63%64.04M
-16.87%17.28M
-26.75%14.05M
-0.75%16.44M
-2.96%16.27M
2.43%73.3M
-10.88%20.78M
Research and development costs
-30.35%33.23M
21.54%40.02M
-58.56%39.15M
-5.08%208.68M
-51.90%33.59M
380.61%47.71M
-66.98%32.93M
40.38%94.46M
9.37%219.84M
19.44%69.84M
Operating profit
29.54%-43.52M
-2.01%-50.36M
54.27%-50.63M
6.97%-272.72M
43.87%-50.87M
-2,731.77%-61.76M
57.54%-49.37M
-31.73%-110.72M
-7.55%-293.14M
-10.80%-90.62M
Net non-operating interest income expense
-61.11%1M
-81.98%577K
-67.30%992K
5.36%10.47M
-39.25%1.66M
-9.89%2.58M
34.88%3.2M
53.54%3.03M
164.17%9.94M
69.00%2.73M
Non-operating interest income
-61.11%1M
-81.98%577K
-67.30%992K
5.36%10.47M
-39.25%1.66M
-9.89%2.58M
34.88%3.2M
53.54%3.03M
164.17%9.94M
69.00%2.73M
Other net income (expense)
148.52%360K
-968.02%-44.01M
15.81%249K
-8,567.31%-4.51M
162.95%141K
-344.88%-742K
-4,805.95%-4.12M
557.45%215K
92.28%-52K
16.42%-224K
Special income (charges)
--0
---44.61M
----
----
----
--0
----
----
----
----
-Less:Impairment of capital assets
--0
--44.61M
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
148.52%360K
114.51%598K
15.81%249K
-8,567.31%-4.51M
162.95%141K
-344.88%-742K
-4,805.95%-4.12M
557.45%215K
92.28%-52K
16.42%-224K
Income before tax
29.66%-42.15M
-86.51%-93.8M
54.05%-49.39M
5.82%-266.76M
44.31%-49.07M
-6,189.84%-59.92M
55.88%-50.29M
-30.87%-107.48M
-5.11%-283.26M
-9.54%-88.12M
Income tax
Net income
29.66%-42.15M
-86.51%-93.8M
54.05%-49.39M
5.82%-266.76M
44.31%-49.07M
-6,189.84%-59.92M
55.88%-50.29M
-30.87%-107.48M
-5.11%-283.26M
-9.54%-88.12M
Net income continuous Operations
29.66%-42.15M
-86.51%-93.8M
54.05%-49.39M
5.82%-266.76M
44.31%-49.07M
-6,189.84%-59.92M
55.88%-50.29M
-30.87%-107.48M
-5.11%-283.26M
-9.54%-88.12M
Minority interest income
Net income attributable to the parent company
29.66%-42.15M
-86.51%-93.8M
54.05%-49.39M
5.82%-266.76M
44.31%-49.07M
-6,189.84%-59.92M
55.88%-50.29M
-30.87%-107.48M
-5.11%-283.26M
-9.54%-88.12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
29.66%-42.15M
-86.51%-93.8M
54.05%-49.39M
5.82%-266.76M
44.31%-49.07M
-6,189.84%-59.92M
55.88%-50.29M
-30.87%-107.48M
-5.11%-283.26M
-9.54%-88.12M
Basic earnings per share
36.00%-0.16
-85.71%-0.39
57.14%-0.21
20.55%-1.16
53.33%-0.21
-5,105.01%-0.25
64.41%-0.21
-13.95%-0.49
-2.10%-1.46
-7.14%-0.45
Diluted earnings per share
36.00%-0.16
-85.71%-0.39
57.14%-0.21
20.55%-1.16
53.33%-0.21
-5,193.72%-0.25
64.41%-0.21
-13.95%-0.49
-2.10%-1.46
-7.14%-0.45
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -29.54%43.52M2.01%50.36M-54.27%50.63M-6.97%272.72M-43.87%50.87M2,731.77%61.76M-57.54%49.37M31.73%110.72M7.55%293.14M10.80%90.62M
Selling and administrative expenses -26.81%10.29M-37.11%10.34M-29.41%11.48M-12.63%64.04M-16.87%17.28M-26.75%14.05M-0.75%16.44M-2.96%16.27M2.43%73.3M-10.88%20.78M
-General and administrative expense -26.81%10.29M-37.11%10.34M-29.41%11.48M-12.63%64.04M-16.87%17.28M-26.75%14.05M-0.75%16.44M-2.96%16.27M2.43%73.3M-10.88%20.78M
Research and development costs -30.35%33.23M21.54%40.02M-58.56%39.15M-5.08%208.68M-51.90%33.59M380.61%47.71M-66.98%32.93M40.38%94.46M9.37%219.84M19.44%69.84M
Operating profit 29.54%-43.52M-2.01%-50.36M54.27%-50.63M6.97%-272.72M43.87%-50.87M-2,731.77%-61.76M57.54%-49.37M-31.73%-110.72M-7.55%-293.14M-10.80%-90.62M
Net non-operating interest income expense -61.11%1M-81.98%577K-67.30%992K5.36%10.47M-39.25%1.66M-9.89%2.58M34.88%3.2M53.54%3.03M164.17%9.94M69.00%2.73M
Non-operating interest income -61.11%1M-81.98%577K-67.30%992K5.36%10.47M-39.25%1.66M-9.89%2.58M34.88%3.2M53.54%3.03M164.17%9.94M69.00%2.73M
Other net income (expense) 148.52%360K-968.02%-44.01M15.81%249K-8,567.31%-4.51M162.95%141K-344.88%-742K-4,805.95%-4.12M557.45%215K92.28%-52K16.42%-224K
Special income (charges) --0---44.61M--------------0----------------
-Less:Impairment of capital assets --0--44.61M--------------0----------------
Other non- operating income (expenses) 148.52%360K114.51%598K15.81%249K-8,567.31%-4.51M162.95%141K-344.88%-742K-4,805.95%-4.12M557.45%215K92.28%-52K16.42%-224K
Income before tax 29.66%-42.15M-86.51%-93.8M54.05%-49.39M5.82%-266.76M44.31%-49.07M-6,189.84%-59.92M55.88%-50.29M-30.87%-107.48M-5.11%-283.26M-9.54%-88.12M
Income tax
Net income 29.66%-42.15M-86.51%-93.8M54.05%-49.39M5.82%-266.76M44.31%-49.07M-6,189.84%-59.92M55.88%-50.29M-30.87%-107.48M-5.11%-283.26M-9.54%-88.12M
Net income continuous Operations 29.66%-42.15M-86.51%-93.8M54.05%-49.39M5.82%-266.76M44.31%-49.07M-6,189.84%-59.92M55.88%-50.29M-30.87%-107.48M-5.11%-283.26M-9.54%-88.12M
Minority interest income
Net income attributable to the parent company 29.66%-42.15M-86.51%-93.8M54.05%-49.39M5.82%-266.76M44.31%-49.07M-6,189.84%-59.92M55.88%-50.29M-30.87%-107.48M-5.11%-283.26M-9.54%-88.12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 29.66%-42.15M-86.51%-93.8M54.05%-49.39M5.82%-266.76M44.31%-49.07M-6,189.84%-59.92M55.88%-50.29M-30.87%-107.48M-5.11%-283.26M-9.54%-88.12M
Basic earnings per share 36.00%-0.16-85.71%-0.3957.14%-0.2120.55%-1.1653.33%-0.21-5,105.01%-0.2564.41%-0.21-13.95%-0.49-2.10%-1.46-7.14%-0.45
Diluted earnings per share 36.00%-0.16-85.71%-0.3957.14%-0.2120.55%-1.1653.33%-0.21-5,193.72%-0.2564.41%-0.21-13.95%-0.49-2.10%-1.46-7.14%-0.45
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -